Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors

Table 3

Cox-regression analyses for overall survival, distant metastases-free survival, and disease-free survival.

	OS; Hazard ratio; (95% CI, value)	DMFS; Hazard ratio; (95% CI, value)	DFS; Hazard ratio; (95% CI, value)
Age (years)
≤40	4.63 (0.83–24.97, 0.097)		3.44 (0.99–11.91, 0.051)
41–64	Reference		Reference
≥65	1.38 (0.22–8.86, 0.734)		1.57 (0.32–7.82, 0.582)
Tumor size (cm)
≤4	Reference	Reference
>4	8.62 (2.73–27.03, <0.001)	5.13 (1.72–15.15, 0.003)
Lymph node involvement
0		Reference	Reference
1–2		3.48 (0.77–15.87, 0.105)	0.72 (0.17–2.98, 0.649)
≥3		4.03 (1.13–14.29, 0.031)	3.90 (1.08–14.07, 0.038)

OS: overall survival; DMFS: distant metastases-free survival; DFS: disease-free survival.